• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number COMMANDER DELIVERY SYSTEM
Device Problems Difficult or Delayed Positioning (1157); Difficult to Remove (1528); Device Slipped (1584); Failure to Align (2522); Material Split, Cut or Torn (4008)
Patient Problem Unspecified Vascular Problem (4441)
Event Date 08/21/2023
Event Type  Death  
Manufacturer Narrative
Investigation is ongoing.Device not returned.
 
Event Description
As reported, patient was accessed via carotid and due to short ascending a portion of alignment was done in sheath.When the valve was pushed out of the sheath and they started the fine tuning the delivery system starting bending at the area near the stent and delivery system so they pulled negative on balloon to see if the bond was broken and there was no blood.They advanced the delivery system across the aortic valve and when unsheathed the stent pulled back close to the middle marker.They tried to see if the balloon would inflate, but contrast went into the patients body and blood came back into the indeflator, the valve would not come back into the sheath, even with changing positioning in aorta and slightly rotating the sheath.They decided to try and put valve against the sheath and pull out as one unit and met resistance at the ostium of the left carotid, the sheath/valve combo came uncoupled so they opened up further to get valve out surgically, gave the valve a small tug and the artery avulsed and came out with the system.It was noted that the three tabs at the bond were up and the distal portion of the valve stent was flared; the area of transition between the balloon and the balloon catheter was the distal portion, the tabs that pop out when the balloon is no longer connected to the balloon catheter were up.The carotid vessels were straight, but small.Angulation of the aorta was 38 degrees.They attempted to balloon occlude for repair, but the non edwards balloon would not provide occlusion even with a 8-9mm ostium - vessel 6mm and patient expired.
 
Manufacturer Narrative
Supplemental report submitted to include additional information received through follow-up.The device was not returned for evaluation as it was discarded.Therefore, a no product return engineering evaluation was performed.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints fine adjust valve alignment difficulty, balloon torn, withdraw difficulty, and valve moves on balloon were unable to be confirmed due to unavailability of the returned device and/or applicable imagery.Engineering was unable to perform any visual examination, functional testing, or dimensional analysis.Therefore, the presence of a manufacturing non-conformance was unable to be determined.A review of ifu/training materials revealed no deficiencies.An existing edwards technical summary has been documented for root cause analysis for valve alignment difficulty and secondary failures due to tension build up in the system, resulting in the reported valve movement on balloon, balloon torn and withdrawal difficulty.The technical summary provides a rationale as to why it is unlikely that a product defect or manufacturing non-conformance contributed to this type of event.Per provided 3mensio, patient had tortuosity in access vessels.If valve alignment was performed in a tortuous vasculature (non-straight section), this could have caused the valve to become unseated (non-coaxial placement of valve in relation to the flex tip) and ''dive'' into the flex tip.If the thv was unseated from the flex tip during alignment, it could have resulted in higher-than-normal alignment forces creating high tension in the system, which could have consequentially led to the reported valve alignment difficulties.Additionally, high forces on the system during valve alignment may result in crimp balloon tearing prior to thv deployment, creating a leak pathway as reported.The release of built-up tension within the delivery system during the procedure may have resulted in the reported valve movement on balloon.Tortuous patient anatomy could result in non-coaxial angles of withdrawal during system retrieval.It is possible that the non-coaxial withdrawal configuration in combination with altered balloon profile (torn) may have resulted in the crimped thv interacting with patient vasculature and causing the reported withdrawal difficulty.In addition, the technical summary outlines the extensive manufacturing mitigations in place to prevent this type of malfunction (visual and dimensional inspections, leak testing, and functional testing that occurs with every manufactured lot).These inspections and testing further support that it is unlikely that a defect present in manufacturing contributed to the complaint.The technical summary also outlines the instructions for valve deployment.It should be noted that these mitigations are still in place.In this case, review of available information suggests that patient factors (tortuosity) and/or procedural factors (valve alignment in the non-straight section, built up tension) contributed to the valve alignment difficulty, valve movement on balloon and balloon torn while procedural factors (non-coaxial withdrawal, withdrawal of torn balloon) contributed to the withdrawal difficulty.These events contributed to the patient death.No device or labeling problem was identified during the evaluation.Therefore, no further escalation (capa/scar/pra) is required.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Event Description
Edwards received notification from a field clinical specialist that a patient underwent trans carotid tavr.As reported, a portion of valve alignment was done in sheath due to short ascending anatomy.The alignment was completed with the fine adjustment knob while inside of the sheath causing the delivery system to bend inside the sheath showing the extreme tension on the system.When the valve was pushed out of the sheath and the team began the fine tuning the delivery system, it started bending at the area near the stent and delivery system.Then the flex catheter was retracted, the valve came with it with the distal portion of the valve stent being at the middle marker.The team pulled negative on the balloon to see if the bond was broken and there was no blood.They tried to see if the balloon would inflate, but contrast went into the patient's body and blood came back into the indeflator.The valve would not come back into the sheath, even with changing positioning in aorta and slightly rotating the sheath.They decided to try and put valve against the sheath and pull out as one unit and met resistance at the ostium of the left carotid, the sheath/valve combo came uncoupled so they opened up further to get valve out surgically, gave the valve a small tug and the artery avulsed and came out with the system.It was noted that the three tabs at the bond were up and the distal portion (the area of transition between the balloon and the balloon catheter) of the valve stent was flared (the tabs that pop out when the balloon is no longer connected to the balloon catheter, were up).The carotid vessels were straight, but small.Angulation of the aorta was 38 degrees.The team attempted to balloon occlude for repair, but the 10mm balloon would not provide occlusion even with a 8-9mm ostium and 6mm vessel.The patient then expired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine MN 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key17754368
MDR Text Key323471656
Report Number2015691-2023-15957
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/15/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCOMMANDER DELIVERY SYSTEM
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Required Intervention;
Patient Age69 YR
Patient SexMale
-
-